ホームポートフォリオウォッチリストコミュニティ発見スクリーナー
NOT FOR DISTRIBUTION
Loading...
  • 株式
  • /
  • 医薬品・バイオテクノロジー
1分前に更新
EAPI logo

Euroapi S.A.ENXTPA:EAPI 株式レポート

時価総額 €74.5m
1分前に更新
株価
n/a
1Y-75.3%
7D-8.5%
1D-8.1%
ポートフォリオ価値
​
表示

Euroapi S.A.

ENXTPA:EAPI 株式レポート

時価総額:€74.5m

  • 会社概要
    • 評価
    • 将来の成長
    • 過去の実績
    • 財務の健全性
    • 配当金
  • マネジメント
  • 所有権
  • その他の情報
  • 株式コミュニティ

Euroapi(EAPI)株式概要

Euroapi S.A.は、ヒトおよび動物用医薬品の製剤に使用される原薬および中間体の開発、製造、販売、流通を行っている。 詳細

EAPI ファンダメンタル分析
スノーフレーク・スコア
評価3/6
将来の成長0/6
過去の実績0/6
財務の健全性5/6
配当金0/6

報酬

同業他社や業界と比較して、良好な取引価格

リスク分析

現在は利益が出ておらず、今後3年間で利益が出る見込みはない

意味のある時価総額がありません ( €75M )

French市場と比較した過去 3 か月間の株価の変動


EAPI Community Fair Values

Create Narrative

See what 11 others think this stock is worth. Follow their fair value or set your own to get alerts.

Analyst Price Targets

AN
AnalystConsensusTarget
35.0% 割安 内在価値ディスカウント
AnalystConsensusTarget
•1mo ago

Capacity Expansion And Biotechnological Processes Will Strengthen API Supply

56
0
7
AN
AnalystLowTarget
11.4% 割高 内在価値ディスカウント
AnalystLowTarget
•1mo ago

Rising Regulatory And Geopolitical Risks Will Undermine API Profits

40
0
0
AN
AnalystHighTarget
54.1% 割安 内在価値ディスカウント
AnalystHighTarget
•2mo ago

Green Chemistry And Domestic Sourcing Will Unlock Secular Demand

26
0
0

Top Analyst Narratives

AN
AnalystConsensusTarget
35.0% 割安 内在価値ディスカウント
AnalystConsensusTarget
•1mo ago

Capacity Expansion And Biotechnological Processes Will Strengthen API Supply

56
0
7
AN
AnalystLowTarget
11.4% 割高 内在価値ディスカウント
AnalystLowTarget
•1mo ago

Rising Regulatory And Geopolitical Risks Will Undermine API Profits

40
0
0
AN
AnalystHighTarget
54.1% 割安 内在価値ディスカウント
AnalystHighTarget
•2mo ago

Green Chemistry And Domestic Sourcing Will Unlock Secular Demand

26
0
0
View all narratives

Euroapi S.A. 競合他社

AB Science

Symbol: ENXTPA:AB
Market cap: €56.4m

THX Pharma Société Anonyme

Symbol: ENXTPA:ALTHX
Market cap: €47.3m

Boiron

Symbol: ENXTPA:BOI
Market cap: €366.3m

Advicenne

Symbol: ENXTPA:ALDVI
Market cap: €12.6m

価格と性能

株価の高値、安値、推移の概要Euroapi
過去の株価
現在の株価€0.78
52週高値€3.44
52週安値€0.78
ベータ0.96
1ヶ月の変化-20.33%
3ヶ月変化-36.27%
1年変化-75.27%
3年間の変化-93.48%
5年間の変化n/a
IPOからの変化-94.23%

最新ニュース

User avatar
ナラティブ更新 • Aug 18

EAPI: Reset P/E Multiple Will Continue To Restrain Future Earnings

Analysts have reduced their fair value estimate for Euroapi from €1.00 to €0.70, citing updated assumptions for discount rates, expected revenue trends, profit margins and future P/E multiples. What’s in the News for Euroapi Analysts adjusted their assumptions for Euroapi’s discount rate, which influenced the latest fair value estimate.
User avatar
ナラティブ更新 • Aug 04

EAPI: Reset Expectations And Lower P E Multiple Could Support Rebound

Analysts have trimmed their fair value estimate for Euroapi, with the updated €1.20 target down from €1.48. This is aligned with recent Street research that reduced the official price target to €1.70 from €2.90 on revised expectations for growth, margins and future P/E levels.
分析記事 • Aug 02

Euroapi S.A. (EPA:EAPI) Just Reported, And Analysts Assigned A €1.20 Price Target

Shareholders in Euroapi S.A. ( EPA:EAPI ) had a terrible week, as shares crashed 20% to €0.98 in the week since its...

Recent updates

User avatar
ナラティブ更新 • Aug 18

EAPI: Reset P/E Multiple Will Continue To Restrain Future Earnings

Analysts have reduced their fair value estimate for Euroapi from €1.00 to €0.70, citing updated assumptions for discount rates, expected revenue trends, profit margins and future P/E multiples. What’s in the News for Euroapi Analysts adjusted their assumptions for Euroapi’s discount rate, which influenced the latest fair value estimate.
User avatar
ナラティブ更新 • Aug 04

EAPI: Reset Expectations And Lower P E Multiple Could Support Rebound

Analysts have trimmed their fair value estimate for Euroapi, with the updated €1.20 target down from €1.48. This is aligned with recent Street research that reduced the official price target to €1.70 from €2.90 on revised expectations for growth, margins and future P/E levels.
分析記事 • Aug 02

Euroapi S.A. (EPA:EAPI) Just Reported, And Analysts Assigned A €1.20 Price Target

Shareholders in Euroapi S.A. ( EPA:EAPI ) had a terrible week, as shares crashed 20% to €0.98 in the week since its...
User avatar
ナラティブ更新 • Jul 14

EAPI: Execution On Efficiency Plans Could Unlock Upside Under Reset Expectations

Analysts have reduced their Euroapi price target to €1.70 from €2.90, citing updated assumptions around revenue growth, profit margins, the discount rate and future P/E expectations. Analyst Commentary Recent commentary around Euroapi has focused on how the lower €1.70 price target aligns with revised expectations for revenue, margins and valuation multiples.
User avatar
ナラティブ更新 • Jun 30

EAPI: Reset Expectations And Higher Future P/E Could Support Rebound

Analysts have reduced their fair value estimate for Euroapi, cutting the price target from €2.00 to about €1.48. This is broadly in line with a recent move by the Street to bring targets down toward €1.70 as they factor in weaker revenue growth expectations and revised profitability assumptions alongside a higher future P/E multiple.
User avatar
ナラティブ更新 • Jun 16

EAPI: Revenue Contraction And Margin Pressure Will Continue To Restrain Future Earnings

Euroapi's analyst price target has been cut by €1.20 to €1.70, as analysts point to updated expectations for revenue contraction, profit margins, and a lower future P/E multiple. Analyst Commentary on Euroapi The latest research on Euroapi highlights a more cautious stance, with a reduced price target and a Neutral rating that suggests limited conviction in a strong near term recovery.
User avatar
ナラティブ更新 • Jun 02

EAPI: Weaker Demand And Margin Pressure Will Drag On Future Earnings

Analysts have cut Euroapi's price target sharply, with recent revisions moving from €2.90 to a range of €1.70 and €1. This reflects more cautious assumptions on revenue trends, margins and a higher P/E multiple applied to the stock.
User avatar
ナラティブ更新 • May 10

EAPI: Lower Expectations On 2026 Outlook Will Support Future Rebound Potential

Euroapi's analyst price target has shifted lower from about €3.08 to €2.00, with analysts pointing to Deutsche Bank's recent cut in its target to €1, along with updated views on revenue growth, profit margin, discount rate and future P/E assumptions. Analyst Commentary Bullish Takeaways Bullish analysts may see the lower price target range, now clustering around €1 to €2, as setting a more conservative bar for execution, which can reduce the risk of further valuation resets if expectations are now better aligned with current fundamentals.
User avatar
ナラティブ更新 • Apr 22

EAPI: Lower Demand And Portfolio Cuts Will Weigh On Future Earnings

Analysts have cut their price target on Euroapi to €1 from €2, with the change framed around more cautious assumptions despite essentially unchanged fair value, discount rate, revenue growth, profit margin and future P/E inputs in the latest update. Analyst Commentary Bearish analysts cutting the price target on Euroapi to €1 from €2 are signaling a more cautious stance around the stock, even though their core valuation inputs such as fair value frameworks, discount rate, revenue growth, profit margin and future P/E assumptions are described as essentially unchanged.
User avatar
ナラティブ更新 • Apr 08

EAPI: Future Cost Controls May Unlock Upside Despite 2026 Sales Headwinds

Analysts now see Euroapi's fair value closer to €2.90, down from €3.50, aligning with a series of lower Street price targets that most recently moved from €2.50 to €2 and then to €1. Analyst Commentary The recent cuts in fair value and Street targets to around €1 to €2 signal a cautious stance from research desks, with the most recent change bringing the target to €1 and maintaining a Sell view.
User avatar
ナラティブ更新 • Mar 25

EAPI: Weaker 2026 Outlook And Portfolio Cuts Will Pressure Earnings Quality

Analysts have cut their price target on Euroapi to €1 from €2, with the shift broadly tied to ongoing caution reflected in recent research commentary that maintains a Sell stance and modest adjustments to revenue growth and profit margin assumptions. Analyst Commentary Recent research updates highlight a series of price target cuts on Euroapi, with bearish analysts reducing their fair value estimates while maintaining a cautious stance on the shares.
User avatar
ナラティブ更新 • Mar 10

EAPI: Weaker 2025 Guidance Will Pressure Margins And Future Earnings Quality

Analysts have cut their Euroapi price target from €2 to €1, reflecting updated assumptions that now factor in lower revenue growth expectations, much slimmer profit margins, and a significantly higher future P/E multiple. Analyst Commentary Recent price target revisions point to a cautious stance from bearish analysts, who appear focused on execution risks and the implications for Euroapi's valuation.
User avatar
ナラティブ更新 • Feb 24

EAPI: Lower 2025 Guidance And Reduced Multiple Will Shape Return Profile

Analysts have trimmed their price target on Euroapi to €2 from €2.50, citing updated assumptions on modest revenue growth, slightly higher profit margins, and a marginally lower future P/E multiple. Analyst Commentary Recent research points to a more cautious stance on Euroapi, with bearish analysts trimming their price targets to €2.
User avatar
ナラティブ更新 • Feb 09

EAPI: Lower 2025 Outlook And Cautious Stance Will Shape Return Profile

Analysts have lowered their price target on Euroapi from €2.50 to €2, citing updated assumptions around discount rates, revenue growth, profit margins and future P/E that collectively suggest a more cautious valuation stance. Analyst Commentary Bearish analysts have recently cut their price target on Euroapi from €2.50 to €2.
User avatar
ナラティブ更新 • Jan 25

EAPI: Execution Risks And Lower Outlook Will Shape Future Return Profile

Narrative update Analysts have trimmed their price target on Euroapi by €0.50 to €2.00, citing updated assumptions on revenue growth, profit margins and forward P/E that keep their stance cautious on the shares. Analyst Commentary Recent research has reinforced a cautious stance on Euroapi, with bearish analysts trimming their price targets to €2.00.
User avatar
ナラティブ更新 • Jan 10

EAPI: Lower Profitability Assumptions And New Partnership Will Shape Future Returns

Analysts have trimmed their price target on Euroapi to €2 from €2.50, citing softer assumptions around revenue growth, profit margins and a higher future P/E multiple as the key drivers of the reset. Analyst Commentary Bearish analysts are signalling a cautious stance on Euroapi by aligning around a lower price target of €2, narrowed from €2.50.
User avatar
ナラティブ更新 • Dec 19

EAPI: Higher Discount Rate Will Outweigh Benefits From New Corticosteroid Partnership

Analysts have slightly reduced their Euroapi price target, reflecting a modest reassessment of fair value. This adjustment accounts for a higher discount rate, even as long term profit margin assumptions edge up and revenue declines appear marginally less severe.
分析記事 • Dec 18

Calculating The Intrinsic Value Of Euroapi S.A. (EPA:EAPI)

Key Insights Using the 2 Stage Free Cash Flow to Equity, Euroapi fair value estimate is €2.68 Euroapi's €2.40 share...
分析記事 • Dec 18

Euroapi S.A. (EPA:EAPI) Not Doing Enough For Some Investors As Its Shares Slump 26%

Euroapi S.A. ( EPA:EAPI ) shareholders that were waiting for something to happen have been dealt a blow with a 26...
分析記事 • Oct 03

Euroapi (EPA:EAPI) Has Debt But No Earnings; Should You Worry?

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...
分析記事 • Aug 02

Euroapi S.A. (EPA:EAPI) Just Released Its Interim Results And Analysts Are Updating Their Estimates

It's been a mediocre week for Euroapi S.A. ( EPA:EAPI ) shareholders, with the stock dropping 12% to €2.79 in the week...
User avatar
新しいナラティブ • Mar 31

Capacity Expansion And Efficiency Improvements Will Shape Future Success

Euroapi focuses on high-margin differentiated APIs and CDMO services to boost sustainable revenue and profit margins through strategic project expansions.
分析記事 • Mar 06

Analyst Estimates: Here's What Brokers Think Of Euroapi S.A. (EPA:EAPI) After Its Annual Report

It's been a good week for Euroapi S.A. ( EPA:EAPI ) shareholders, because the company has just released its latest...
分析記事 • Oct 04

Euroapi S.A.'s (EPA:EAPI) Intrinsic Value Is Potentially 25% Below Its Share Price

Key Insights The projected fair value for Euroapi is €2.62 based on 2 Stage Free Cash Flow to Equity Current share...
分析記事 • Jul 29

There's No Escaping Euroapi S.A.'s (EPA:EAPI) Muted Revenues Despite A 32% Share Price Rise

Euroapi S.A. ( EPA:EAPI ) shares have had a really impressive month, gaining 32% after a shaky period beforehand...
分析記事 • May 24

Euroapi S.A. (EPA:EAPI) Stock Catapults 29% Though Its Price And Business Still Lag The Industry

Those holding Euroapi S.A. ( EPA:EAPI ) shares would be relieved that the share price has rebounded 29% in the last...
分析記事 • Apr 10

Euroapi (EPA:EAPI) Seems To Be Using A Lot Of Debt

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
分析記事 • Mar 03

Little Excitement Around Euroapi S.A.'s (EPA:EAPI) Revenues As Shares Take 31% Pounding

The Euroapi S.A. ( EPA:EAPI ) share price has fared very poorly over the last month, falling by a substantial 31%. For...
分析記事 • Mar 02

Euroapi S.A. Reported A Surprise Loss, And Analysts Have Updated Their Forecasts

There's been a major selloff in Euroapi S.A. ( EPA:EAPI ) shares in the week since it released its yearly report, with...
分析記事 • Dec 21

A Look At The Fair Value Of Euroapi S.A. (EPA:EAPI)

Key Insights Using the 2 Stage Free Cash Flow to Equity, Euroapi fair value estimate is €5.03 With €5.47 share price...

株主還元

EAPIFR PharmaceuticalsFR 市場
7D-8.5%0.7%-1.4%
1Y-75.3%-4.4%-2.4%

業界別リターン: EAPI過去 1 年間で-4.4 % の収益を上げたFrench Pharmaceuticals業界を下回りました。

リターン対市場: EAPIは、過去 1 年間で-2.4 % のリターンを上げたFrench市場を下回りました。

価格変動

Is EAPI's price volatile compared to industry and market?
EAPI volatility
EAPI Average Weekly Movement7.8%
Pharmaceuticals Industry Average Movement5.3%
Market Average Movement4.2%
10% most volatile stocks in FR Market8.6%
10% least volatile stocks in FR Market2.1%

安定した株価: EAPIの株価は、 French市場と比較して過去 3 か月間で変動しています。

時間の経過による変動: EAPIの weekly volatility ( 8% ) は過去 1 年間安定していますが、依然としてFrenchの株式の 75% よりも高くなっています。

会社概要

設立従業員CEO(最高経営責任者ウェブサイト
20202,961David Seignollewww.euroapi.com/en

Euroapi S.A.は、ヒトおよび動物用医薬品の製剤化に使用される医薬品有効成分および中間体の開発、製造、販売、流通を行っている。同社は、固相化学、粒子工学、微生物発酵、低分子合成、プロスタグランジン、ステロイドとホルモン、アヘン剤と規制薬物、脂質を使用する様々なクラスのタイドの受託開発製造組織を提供している。同社は、製薬会社、ジェネリック医薬品メーカー、動物用医薬品メーカー、消費者向け健康・栄養・化粧品メーカー、バイオテクノロジー企業、流通企業、開発・製造受託機関などに製品を提供している。同社は2020年に設立され、フランス・パリに本社を置いている。

Euroapi S.A. 基礎のまとめ

Euroapi の収益と売上を時価総額と比較するとどうか。
EAPI 基礎統計学
時価総額€74.51m
収益(TTM)-€324.20m
売上高(TTM)€794.60m
0.1x
P/Sレシオ
-0.2x
PER(株価収益率

EAPI は割高か?

公正価値と評価分析を参照

収益と収入

最新の決算報告書(TTM)に基づく主な収益性統計
EAPI 損益計算書(TTM)
収益€794.60m
売上原価€670.50m
売上総利益€124.10m
その他の費用€448.30m
収益-€324.20m

直近の収益報告

Jun 30, 2026

次回決算日

該当なし

一株当たり利益(EPS)-3.39
グロス・マージン15.62%
純利益率-40.80%
有利子負債/自己資本比率13.5%

EAPI の長期的なパフォーマンスは?

過去の実績と比較を見る

企業分析と財務データの現状

データ最終更新日(UTC時間)
企業分析2026/09/20 18:43
終値2026/09/18 00:00
収益2026/06/30
年間収益2025/12/31

データソース

企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。

パッケージデータタイムフレーム米国ソース例
会社財務10年
  • 損益計算書
  • キャッシュ・フロー計算書
  • 貸借対照表
  • SECフォーム10-K
  • SECフォーム10-Q
アナリストのコンセンサス予想+プラス3年
  • 予想財務
  • アナリストの目標株価
  • アナリストリサーチレポート
  • Blue Matrix
市場価格30年
  • 株価
  • 配当、分割、措置
  • ICEマーケットデータ
  • SECフォームS-1
所有権10年
  • トップ株主
  • インサイダー取引
  • SECフォーム4
  • SECフォーム13D
マネジメント10年
  • リーダーシップ・チーム
  • 取締役会
  • SECフォーム10-K
  • SECフォームDEF 14A
主な進展10年
  • 会社からのお知らせ
  • SECフォーム8-K

* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。

特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM(Trailing Twelve Month)またはLTM(Last Twelve Month)データとして知られています。詳細はこちら。

分析モデルとスノーフレーク

このレポートを生成するために使用した分析モデルの詳細は、当社のGitHubページでご覧いただけます。また、レポートの活用方法に関するガイドやYouTubeのチュートリアルも用意しています。

シンプリー・ウォールストリート分析モデルを設計・構築した ご紹介します。

業界およびセクターの指標

私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。

アナリスト筋

Euroapi S.A. 4 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。13

アナリスト機関
Justin Steven SmithBernstein
Patrick Andrew WoodBofA Global Research
Fynn ScherzlerDeutsche Bank

どこでもより良い投資判断を

スキャンしてダウンロード
App Store を開くGoogle Play を開く
Chrome ウェブストア
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
データソースを見る
市場
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
投資のアイデア
  • 割安企業
  • 配当優良企業
  • インサイダー買い
  • 原子力
  • 自律走行車
  • 人工知能
  • 暗号資産とブロックチェーン
  • サイバーセキュリティ
  • さらにアイデア
株価コミュニティ
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
機能とツール
  • ポートフォリオ・トラッカー
  • ストックスクリーナー&アラート
  • 語りと公正な値
  • 配当金計算機
ニュース & 発見
  • 最新の在庫ニュース
  • グローバルマーケットインサイト
  • The Foxhole ブログ
  • 投資のアイデア
  • コミュニティの物語
  • 新着情報
Simply Wall St
  • プランと料金
  • 広告
  • 会社概要
  • お問い合わせ
  • 採用情報
  • ヘルプセンター
  • 株式投資を学ぶ
  • アフィリエイト・プログラム
  • ビジネス
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • ご利用条件
  • プライバシーポリシー
  • AI利用規約
  • 金融サービスガイド